COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
Featuring academic partners from the Burnet Institute, the National Drug and Alcohol Research Centre, the Kirby Institute, Turning Point Alcohol and Drug Centre, the National Drug Research Institute and the School of Population Health at the University of Queensland, the Centre unites Australia’s leading researchers with community organisations, Anex, Harm Reduction Victoria, Hepatitis C Victoria and government, including the ACT Corrections Health Program.
Between researchers and workers in the fields of justice health, mental health, blood-borne virus infection, alcohol and drug use, addiction and policy research.
For students, early-career researchers and community sector workers in disciplines relating to the health of people who inject drugs.
Research findings and translation of research into policy and practice.
Provision of seed funding to support new and novel research projects.
Burnet’s Professor Margaret Hellard, a Lead Investigator with CREIDU, says the strengthened links forged between researchers also benefits the communities they serve.
“The Centre’s focus is to increase our knowledge about IDU and its health and social effects, so ultimately we can identify ways to prevent or reduce the severity of health and social outcomes through policy and practice.“ she said.
“What also makes this NHMRC-funded project unique is that we also bring together experts from IDU-related areas such as blood-borne virus, epidemiology and treatment (particularly hepatitis C), overdose prevention, justice health and psychiatric health.
“Australia’s research capacity in illicit drug epidemiology will also be enhanced by CREIDU supporting postdoctoral-fellows and PhD students.”
Find out more about the investigators, the research projects underway and the policy briefs at www.creidu.edu.au
Among the Policy Briefs available on the CREIDU website are:
CREIDU is funded by the National Health and Medical Research Council (NHMRC). Grant Number 1001144.